The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

Morocco has taken a major step forward in medical genetics with the introduction of Whole Exome Sequencing (WES).

Initiatives under this partnership include non-invasive prenatal testing, targeted next-generation sequencing for TB and ...

The partnership between Vgenomics and Meril Genomics brings advanced genomic tools like NIPT, TB sequencing, and rare disease ...

But, although exome sequencing has shortened the diagnostic odyssey for some individuals and families, it still leaves as many as 75% of cases unsolved. That should be no surprise. The exome ...

Identifying the DPH2 gene mutation enables healthcare providers to consider genetic counselling for families with a history ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced the launch of Oncodetecttm?a new test designed to detect molecular residual disease (MRD) across ...

Vgenomics & Meril Genomics collaborate to revolutionize precision medicine in India: Our Bureau, Mumbai Monday, April 21, 2025, 15:30 Hrs [IST] Vgenomics, a leading precision heal ...

A new study published in Genetics in Medicine identifies a novel disease-associated gene, GPKOW, that plays an important role ...

Vgenomics a leading precision health company and Meril Genomics a trusted diagnostics and molecular biology provider have announced a groundbreaking partnership aimed at providing complementary ...

The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on ...